Professor David Vaux was appointed as a new fellow of the AAHMS at a ceremony in Canberra. The academy promotes medical research and its translation to enable a healthier community both in Australia and globally. Fellows are elected for outstanding leadership and distinguished professional achievement in their field.
In 1988 Professor Vaux and his colleagues made a discovery that launched the molecular era of cell death research. The discovery began a 25-year research program that has led to the development of an anti-cancer drug that is now in phase 3 clinical trials in Melbourne and worldwide.